El interés en corto de Dolby Laboratories da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Dolby Laboratories. Los datos de interés en corto se actualizan cada dos semanas.

Dolby Laboratories (NYSE:DLB) Bolsa, Informe de interés en corto

DOLBY LABORATORIES INC-CL A

Dolby Laboratories

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.

AMCNew,York,,Usa,-,September,14,,2023:,Amc,Sign,Near

News

Movers

AMC ampliará Dolby Cinema en EE.UU., pero sus acciones bajan un 2,13 %. ¿Cómo afectará esto a su futuro en la industria?

AMC expande Dolby Cinema, pero sus acciones caen

AAPL

AKAM

AVGO

DOCU

ENPH

FSLR

GOOG

GOOGL

TSLA

Acciones tecnológicas con valoraciones atractivas y gran potencial de crecimiento. Desde energía renovable hasta TI, descubre dónde invertir.

Acciones tecnológicas con valoraciones atractivas en 2025: ¿Dónde invertir con menor riesgo?

Dolby Laboratories Inc

Movie theater operator AMC Entertainment Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) is betting big on premium screens to add to its revenue over the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44562437/whats-going-on-with-amc-entertainment-stock-monday">next several years.</a>
The move comes with several of the top film franchises of all time having movies set for release.
What Happened: The <a href="https://www.benzinga.com/general/entertainment/24/12/42750888/top-anticipated-2025-movies-for-big-screen-success-and-stocks-investors-should-watch">2025 theatrical movie lineup </a>includes three Marvel films from Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and plenty of other highly anticipated movies from franchises of old and new.
While 2025 could have a strong post-COVID-19 box office total, AMC has its sights set on 2025, 2026 and 2027.
The company recently announced it was adding 40 Dolby Cinema theaters through the end of 2027. The new additions will bring AMC's total number of Dolby premium screens to more than 200, as reported by <a href="https://www.cnbc.com/2025/03/31/amc-premium-screens-hollywood-movies.html">CNBC</a>.
"Premium moviegoing is defining the modern box office," Dolby Laboratories CEO Kevin Yeaman said.
Dolby Laboratories Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is one of several premium screen formats and partners with AMC.
AMC also recently announced a partnership with CJ 4DPLEX for 40 4DX theaters and 25 SCREENX theaters to be opened across the U.S. and Europe beginning in the summer of 2025. This marks the first partnership between the two companies.
The premium format movie screens being added come ahead of a strong movie lineup that AMC CEO Adam Aron has been highlighting for more than a year. From 2025 to 2027, new films will be released from the Star Wars, Jurassic Park, Avatar, Marvel, DC Comics and Mission Impossible franchises.
Premium large format screens come with a higher ticket price for consumers and a way for AMC to add to its overall revenue. PLFs made up around 9.1% of the 2024 domestic box office, representing a total of $600 million split between multiple theater companies.
AMC has over 900 movie theaters and 10,000 screens worldwide as the world's largest movie theater company. The newest bets on premium format screens could add to the company's excitement for the coming box office lineup.
In <a href="https://www.benzinga.com/general/entertainment/25/02/43958798/amc-q4-earnings-revenue-beat-eps-in-line-attendance-up-20-shares-climb">the fourth quarter</a>, AMC reported attendance of 62.42 million, which was up 20.2% year-over-year. The company also reported its highest fourth-quarter food and beverage per person revenue in company history.
With higher attendance and more revenue from premium screens, along with increasing food and beverage revenue, the next three years could be key to the AMC turnaround story.
Read Also: <a href="https://www.benzinga.com/general/entertainment/24/05/39010959/amc-ceo-says-were-still-here-how-taylor-swift-popcorn-buckets-help-movie-theater-from-going">AMC CEO Says &#8216;We&#8217;re Still Here&#8217;: How Taylor Swift, Popcorn Buckets Help Movie Theater From Going &#8216;Kaplooey&#8217;</a>
AMC Post-COVID-19: For several years, Aron has discussed the <a href="https://www.benzinga.com/general/entertainment/24/04/38184776/amc-ceo-says-bankruptcy-is-inconceivable-as-shares-hit-52-week-lows-2025-2026-are-going-to-">post-COVID-19 recovery efforts</a> from AMC, which have included focusing on food and beverage and non-movie opportunities such as Taylor Swift concert films to offset less blockbuster movie releases.
A recent <a href="https://x.com/CEOAdam/status/1906823615737413781">tweet </a>from Aron mentioning the post-COVID-19 time period caught a reply of "the only CEO in the world still talking about covid!" from a social media user.
Aron felt the need to reply with "the facts" that people want to ignore.
"The industry-wide domestic box office in movie theatres was over $11 billion five years in a row pre-Covid. It was over $10 billion eleven years in a row pre-Covid," Aron said.
The CEO said the industry posted domestic box office of $8.8 billion in 2024, down over 20% from 2019 levels.
"When a high fixed cost industry like the movie theatre industry loses 20% of its revenue, its profits and cash balances plummet by far more."
Aron said the movie theater industry "has not fully recovered yet" and the recovery is taking longer than many expected or hoped.
"We are optimistic that a rising box office over the next year or two will be a great boon for AMC."
Aron also brushed off concerns about his salary in another <a href="https://x.com/CEOAdam/status/1907002331906077007">tweet</a>.
"I understand why you would be distraught if my salary was $23 million per year. Except that it isn't."
Aron said his salary is $1.5 million annually, as he has requested no raises. He is also paid cash bonuses related to company performance. The CEO said these amounts are less than one-third of his publicly reported total compensation, due to reporting of AMC share compensation.
"The bulk of my total compensation is in AMC stock."
Aron said he has not sold one share of AMC stock in more than three years. 
AMC Price Action: AMC stock is down 2.95% to $2.80 on Tuesday versus a 52-week trading range of $2.38 to $11.88. AMC stock is down 30.9% year-to-date in 2025.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44442150/meme-stock-meets-ai-how-amc-could-help-moviegoers-never-see-subtitles-again">Meme Stock Meets AI: How AMC Could Help Moviegoers Never See Subtitles Again</a></li>
</ul>
Photo: Shutterstock

Entertainment

Trading Ideas

AMC CEO Bets Big On Star Wars, Avatar, Jurassic Park, Marvel Franchises By Adding More Premium Screens

AMC Entertainment Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) shares are trading lower. The company on Monday announced a major expansion of Dolby Cinema at <a href="https://www.benzinga.com/pressreleases/25/03/n44560135/dolby-and-amc-entertainment-announce-major-expansion-of-dolby-cinema-at-amc-in-the-us-with-40-addi">AMC theaters in the United States</a>.
What Happened: AMC and Dolby Laboratories Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) announced an expanded partnership to add 40 additional Dolby Cinemas at AMC locations in the U.S. through 2027.
The expansion will bring AMC&#8217;s total Dolby Cinema theaters to over 200. The companies also agreed to extend their commitment to the existing Dolby Cinema network.
&#8220;For a decade, AMC and Dolby have provided moviegoers with incredible premium experiences &#8211; making the biggest blockbusters even bigger, brighter, louder, and more immersive,&#8221; said&nbsp;Adam Aron, chairman and CEO of AMC Entertainment. 
&#8220;The expansion of this partnership is a powerful demonstration of AMC&#8217;s ongoing commitment to deliver this premium experience – sought out by filmmakers, studio partners, and our guests – to even more of our theaters and AMC moviegoers around&nbsp;the United States.&#8221;
In addition to the new locations, AMC said it also selected Dolby Vision as its HDR offering of choice. The company noted that 49 of the top 50 movies over the past five years were shown in Dolby Cinema theaters.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44551992/ripples-legal-win-bitcoin-demand-robinhoods-banking-vision-and-gamestops-bitcoin-strategy-this-week-in-crypto">Ripple&#8217;s Legal Win, Bitcoin Demand, Robinhood&#8217;s Banking Vision, And Gamestop&#8217;s Bitcoin Strategy: This Week In Crypto</a>
When AMC reported <a href="https://www.benzinga.com/general/entertainment/25/02/43958798/amc-q4-earnings-revenue-beat-eps-in-line-attendance-up-20-shares-climb">fourth-quarter financial results</a> last quarter, the company noted that it planned to work on expanding its premium large format, extra-large format and special purpose screens in 2025.
Fourth-quarter attendance totaled 62.42 million, up 20.2% on a year-over-year basis. AMC said U.S. attendance came in at 42.96 million, up 21.1% year-over-year.
&#8220;As we look ahead to 2025 and beyond, we look forward to what we believe will be material growth in the industry-wide box office. To best benefit from such growth, we remain committed to continually improving the experience in our theatres for our guests,&#8221; Aron said last month.
AMC Price Action: <a href="http://benzinga.com/quote/amc">AMC shares</a> were down 2.13% at $2.82 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Photo: Shutterstock.

What's Going On With AMC Entertainment Stock Monday?

Barrington Research analyst Patrick Sholl maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Outperform and maintains $100 price target.

Price Target

Analyst Ratings

Barrington Research Maintains Outperform on Dolby Laboratories, Maintains $100 Price Target

New Interoperability Agreement Accelerates Wireless Audio Integration for Android and Linux A/V Platforms
WiSA Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISA#NASDAQ">WISA</a>), soon to be doing business as Datavault&#xAE; AI, today announced a new interoperability license agreement with Dolby. This agreement allows Datavault AI to collaborate directly with system-on-chip (SoC) providers to integrate its patented WiSA E Express multichannel wireless audio software into Android and future Linux-based streaming A/V platforms.

WISA

WiSA Technologies Soon To Be Doing Business As Datavault AI, Signs Interoperability License Agreement With Dolby; Accelerating Wireless Audio Integration For Android And Linux A/V Platforms

WIIM

Dolby Laboratories shares are trading higher after the company reported better-than-expected Q1 financial results.

Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) with a Buy and maintains $100 price target.

Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $100 Price Target

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) just disclosed its Q1 earnings on Wednesday, January 29, 2025 at 04:15 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Past Earnings Performance</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 16.0% increase change in the share price the following day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Dolby Laboratories management provided guidance for FY 2025, expecting earnings between $3.99 and $4.14 per share.
To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Recap: Dolby Laboratories Q1 Earnings

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) reported its Q1 earnings results on Wednesday, January 29, 2025 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 16.0% increase in the share price the next day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Dolby Laboratories management provided guidance for FY 2025, expecting earnings between $3.99 and $4.14 per share.
To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: Dolby Laboratories Q1

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is looking for Q2 GAAP EPS of $0.77-0.92 vs $0.97 analyst estimate..

Guidance

Dolby Laboratories Sees Q2 2025 GAAP EPS $0.77-0.92 vs $0.97 Est

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is looking for Q2 Adj EPS of $1.19-1.34 vs $1.35 analyst estimate. sees sales of $355.000 million-385.000 million vs $387.20 million estimate.

Dolby Laboratories Sees Q2 2025 Adj EPS $1.19-1.34 vs $1.35 Est; Sees Sales $355.000M-385.000M vs $387.20M Est

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) lowers FY2025 GAAP EPS guidance from $2.43-2.58 to $2.39-2.54 vs $2.50 analyst estimate..

Dolby Laboratories Lowers FY2025 GAAP EPS Guidance from $2.43-2.58 to $2.39-2.54 vs $2.50 Est

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) affirms FY2025 Adj EPS guidance from $3.99-4.14 to $3.99-4.14 vs $4.06 analyst estimate. Affirms FY2025 sales outlook from $1.33 billion-1.39 billion to $1.33 billion-1.39 billion vs $1.36 billion estimate.

Dolby Laboratories Affirms FY2025 Adj EPS Guidance from $3.99-4.14 to $3.99-4.14 vs $4.06 Est; Affirms FY2025 Sales Guidance from $1.33B-1.39B to $1.33B-1.39B vs $1.36B Est

The earnings results for Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) for Q1 were made public on Wednesday, January 29, 2025 at 04:15 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Historical Earnings Summary</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 16.0% increase change in the share price the following day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Dolby Laboratories management provided guidance for FY 2025, expecting earnings between $3.99 and $4.14 per share.
To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dolby Laboratories Earnings Review: Q1 Summary

The earnings results for Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) for Q1 were made public on Wednesday, January 29, 2025 at 04:15 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
In the previous quarter, the company beat on EPS by $0.11, resulting in a 16.0% increase change in the share price the following day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Dolby Laboratories management provided guidance for FY 2025, expecting earnings between $3.99 and $4.14 per share.
To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dolby Laboratories Q1 Earnings Assessment

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) just disclosed its Q1 earnings on Wednesday, January 29, 2025 at 04:15 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company beat on EPS by $0.11 in the last quarter, resulting in a 16.0% increase share price change the following day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Dolby Laboratories management provided guidance for FY 2025, expecting earnings between $3.99 and $4.14 per share.
To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dolby Laboratories: Q1 Earnings Insights

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) released its Q1 earnings on Wednesday, January 29, 2025 at 04:15 PM.
Here's what's important from the earnings announcement.
<h3>Earnings</h3>
Dolby Laboratories beat estimated earnings by 16.0%, reporting an EPS of $1.14 versus an estimate of $0.98.
Revenue was up $41.42 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
Last quarter the company beat on EPS by $0.11 which was followed by a 16.0% increase in the share price the next day.
Here's a look at Dolby Laboratories's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.70</td>
<td>0.59</td>
<td>1.19</td>
<td>0.86</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.81</td>
<td>0.71</td>
<td>1.27</td>
<td>1.01</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>307.94M</td>
<td>286.18M</td>
<td>359.44M</td>
<td>312.87M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>304.81M</td>
<td>288.82M</td>
<td>364.52M</td>
<td>315.57M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Dolby Laboratories <a href="https://www.benzinga.com/quote/DLB/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Dolby Laboratories Earnings Analysis: Q1 Recap

Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) reported quarterly earnings of $1.14 per share which beat the analyst consensus estimate of $1.05 by 8.57 percent. This is a 12.87 percent increase over earnings of $1.01 per share from the same period last year. The company reported quarterly sales of $357.00 million which beat the analyst consensus estimate of $346.15 million by 3.14 percent. This is a 13.13 percent increase over sales of $315.57 million the same period last year.

Earnings Beats

Dolby Laboratories Q1 2025 Adj EPS $1.14 Beats $1.05 Estimate, Sales $357.00M Beat $346.15M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Stifel Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SF#NYSE">SF</a>) is likely to report quarterly earnings at $1.97 per share on revenue of $1.28 billion. 
• Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $385.34 million. 
• Otis Worldwide (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OTIS#NYSE">OTIS</a>) is likely to report quarterly earnings at $0.96 per share on revenue of $3.63 billion. 
• Teva Pharmaceutical Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>) is projected to report quarterly earnings at $0.70 per share on revenue of $4.12 billion. 
• Wabash National (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNC#NYSE">WNC</a>) is expected to report quarterly earnings at $0.03 per share on revenue of $412.92 million. 
• Flex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLEX#NASDAQ">FLEX</a>) is likely to report quarterly earnings at $0.63 per share on revenue of $6.20 billion. 
• Southside Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SBSI#NYSE">SBSI</a>) is projected to report quarterly earnings at $0.71 per share on revenue of $68.12 million. 
• MSCI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSCI#NYSE">MSCI</a>) is estimated to report quarterly earnings at $3.96 per share on revenue of $747.63 million. 
• Hess Midstream (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HESM#NYSE">HESM</a>) is estimated to report quarterly earnings at $0.75 per share on revenue of $388.90 million. 
• Monro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNRO#NASDAQ">MNRO</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $311.88 million. 
• Central Pacific Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPF#NYSE">CPF</a>) is estimated to report quarterly earnings at $0.62 per share on revenue of $67.00 million. 
• Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>) is likely to report quarterly earnings at $4.00 per share on revenue of $575.21 million. 
• Blue Foundry (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLFY#NASDAQ">BLFY</a>) is likely to report quarterly loss at $0.17 per share on revenue of $10.02 million. 
• Avnet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVT#NASDAQ">AVT</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $5.56 billion. 
• Coda Octopus Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODA#NASDAQ">CODA</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $5.27 million. 
• Norfolk Southern (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSC#NYSE">NSC</a>) is likely to report quarterly earnings at $2.97 per share on revenue of $3.03 billion. 
• Extreme Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXTR#NASDAQ">EXTR</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $278.05 million. 
• Group 1 Automotive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPI#NYSE">GPI</a>) is estimated to report quarterly earnings at $9.09 per share on revenue of $5.21 billion. 
• Brinker International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $1.12 billion. 
• Silgan Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLGN#NYSE">SLGN</a>) is likely to report quarterly earnings at $0.83 per share on revenue of $1.40 billion. 
• VF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VFC#NYSE">VFC</a>) is likely to report quarterly earnings at $0.33 per share on revenue of $2.75 billion. 
• Hess (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HES#NYSE">HES</a>) is expected to report quarterly earnings at $1.50 per share on revenue of $3.05 billion. 
• Navient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAVI#NASDAQ">NAVI</a>) is projected to report quarterly earnings at $0.26 per share on revenue of $136.80 million. 
• Nasdaq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDAQ#NASDAQ">NDAQ</a>) is expected to report quarterly earnings at $0.75 per share on revenue of $1.22 billion. 
• CGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIB#NYSE">GIB</a>) is likely to report quarterly earnings at $1.40 per share on revenue of $2.64 billion. 
• Prosperity Bancshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PB#NYSE">PB</a>) is expected to report quarterly earnings at $1.33 per share on revenue of $303.21 million. 
• Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) is expected to report quarterly earnings at $3.56 per share on revenue of $18.76 billion. 
• General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>) is expected to report quarterly earnings at $4.23 per share on revenue of $13.21 billion. 
• Applied Industrial Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIT#NYSE">AIT</a>) is expected to report quarterly earnings at $2.21 per share on revenue of $1.08 billion. 
• T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) is projected to report quarterly earnings at $2.30 per share on revenue of $21.37 billion. 
• Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $3.76 billion. 
• Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) is expected to report quarterly earnings at $4.14 per share on revenue of $1.23 billion. 
• M/I Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHO#NYSE">MHO</a>) is likely to report quarterly earnings at $4.83 per share on revenue of $1.17 billion. 
• Danaher (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>) is projected to report quarterly earnings at $2.15 per share on revenue of $6.39 billion. 
• Scotts Miracle Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>) is likely to report quarterly loss at $1.23 per share on revenue of $392.29 million. 
• Automatic Data Processing (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADP#NASDAQ">ADP</a>) is expected to report quarterly earnings at $2.30 per share on revenue of $4.97 billion. 
• ASML Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASML#NASDAQ">ASML</a>) is expected to report quarterly earnings at $6.71 per share on revenue of $9.02 billion. 
<h3>Companies Reporting After The Bell</h3>
• Whirlpool (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WHR#NYSE">WHR</a>) is likely to report quarterly earnings at $4.31 per share on revenue of $4.23 billion. 
• Las Vegas Sands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) is estimated to report quarterly earnings at $0.58 per share on revenue of $2.91 billion. 
• John B Sanfilippo &amp; Son (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBSS#NASDAQ">JBSS</a>) is likely to report earnings for its second quarter. 
• Wolfspeed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOLF#NYSE">WOLF</a>) is projected to report quarterly loss at $1.00 per share on revenue of $179.89 million. 
• Robert Half (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHI#NYSE">RHI</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $1.39 billion. 
• Bassett Furniture Indus (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSET#NASDAQ">BSET</a>) is projected to report quarterly loss at $0.01 per share on revenue of $82.97 million. 
• Two Harbors Inv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWO#NYSE">TWO</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $-21 million. 
• Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $1.10 billion. 
• Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is projected to report quarterly earnings at $0.76 per share on revenue of $27.12 billion. 
• Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) is estimated to report quarterly earnings at $0.91 per share on revenue of $740.91 million. 
• Washington Trust Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WASH#NASDAQ">WASH</a>) is estimated to report quarterly earnings at $0.58 per share on revenue of $48.36 million. 
• Waste Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WM#NYSE">WM</a>) is estimated to report quarterly earnings at $1.79 per share on revenue of $5.90 billion. 
• Meritage Homes (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTH#NYSE">MTH</a>) is likely to report quarterly earnings at $1.10 per share on revenue of $1.57 billion. 
• Western Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDC#NASDAQ">WDC</a>) is projected to report quarterly earnings at $1.84 per share on revenue of $4.26 billion. 
• First Interstate BancSys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIBK#NASDAQ">FIBK</a>) is projected to report quarterly earnings at $0.46 per share on revenue of $251.46 million. 
• Benchmark Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHE#NYSE">BHE</a>) is projected to report quarterly earnings at $0.56 per share on revenue of $660.00 million. 
• United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) is likely to report quarterly earnings at $11.71 per share on revenue of $3.94 billion. 
• Landstar System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTR#NASDAQ">LSTR</a>) is estimated to report quarterly earnings at $1.34 per share on revenue of $1.20 billion. 
• Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) is estimated to report quarterly earnings at $0.88 per share on revenue of $4.32 billion. 
• High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>) is estimated to report quarterly loss at $0.02 per share on revenue of $99.08 million. 
• Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) is expected to report quarterly earnings at $3.12 per share on revenue of $68.86 billion. 
• Liberty Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) is expected to report quarterly earnings at $0.15 per share on revenue of $994.31 million. 
• Methanex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) is expected to report quarterly earnings at $1.07 per share on revenue of $994.61 million. 
• Annaly Capital Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $1.26 billion. 
• Hawkins (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWKN#NASDAQ">HWKN</a>) is expected to report quarterly earnings at $0.92 per share on revenue of $219.22 million. 
• Levi Strauss (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>) is estimated to report quarterly earnings at $0.48 per share on revenue of $1.73 billion. 
• Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) is likely to report quarterly earnings at $9.19 per share on revenue of $4.47 billion. 
• Ethan Allen Interiors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETD#NYSE">ETD</a>) is likely to report quarterly earnings at $0.61 per share on revenue of $160.60 million. 
• Selective Insurance Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIGI#NASDAQ">SIGI</a>) is estimated to report quarterly earnings at $2.01 per share on revenue of $1.27 billion. 
• ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) is projected to report quarterly earnings at $3.65 per share on revenue of $2.96 billion. 
• SEI Inv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEIC#NASDAQ">SEIC</a>) is likely to report quarterly earnings at $1.20 per share on revenue of $555.43 million. 
• Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) is expected to report quarterly earnings at $1.05 per share on revenue of $346.15 million. 
• Celestica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) is likely to report quarterly earnings at $1.04 per share on revenue of $2.51 billion. 
• Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is projected to report quarterly earnings at $6.73 per share on revenue of $46.98 billion. 
• Raymond James Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RJF#NYSE">RJF</a>) is expected to report quarterly earnings at $2.66 per share on revenue of $3.47 billion. 
• National Fuel Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NFG#NYSE">NFG</a>) is estimated to report quarterly earnings at $1.53 per share on revenue of $615.17 million. 
• MaxLinear (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) is estimated to report quarterly loss at $0.13 per share on revenue of $90.00 million. 
• Brookline Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKL#NASDAQ">BRKL</a>) is likely to report quarterly earnings at $0.24 per share on revenue of $90.68 million. 
• Canadian Pacific Kansas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CP#NYSE">CP</a>) is estimated to report quarterly earnings at $1.27 per share on revenue of $3.96 billion. 
• IBM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) is likely to report quarterly earnings at $3.79 per share on revenue of $17.60 billion. 
• Bridgewater Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWB#NASDAQ">BWB</a>) is expected to report quarterly earnings at $0.24 per share on revenue of $27.65 million. 
• Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) is estimated to report quarterly earnings at $2.53 per share on revenue of $1.33 billion. 
• C.H. Robinson Worldwide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHRW#NASDAQ">CHRW</a>) is estimated to report quarterly earnings at $1.11 per share on revenue of $4.43 billion. 
• Core Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLB#NYSE">CLB</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $133.59 million. 
• Calix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CALX#NYSE">CALX</a>) is expected to report quarterly earnings at $0.07 per share on revenue of $203.91 million. 
• Cimpress (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPR#NASDAQ">CMPR</a>) is projected to report quarterly earnings at $2.38 per share on revenue of $968.96 million. 
• Century Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCS#NYSE">CCS</a>) is projected to report quarterly earnings at $3.18 per share on revenue of $1.28 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASML

BLFY

BRKL

BSET

CALX

CHRW

CMPR

CODA

EXTR

FIBK

FLEX

HESM

HITI

HWKN

JBSS

LBRT

LEVI

LRCX

LSTR

MEOH

MNRO

MSCI

MSFT

NAVI

NDAQ

OTIS

SBSI

SEIC

SIGI

SLGN

TEVA

TMUS

TTEK

VIRT

WASH

WOLF

Earnings Scheduled For January 29, 2025

Across the recent three months, 4 analysts have shared their insights on Dolby Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $100.0, along with a high estimate of $100.00 and a low estimate of $100.00. Observing a 0.5% increase, the current average has risen from the previous average price target of $99.50. 
<img src="https://www.benzinga.com/files/images/story/2025/1737982871_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Dolby Laboratories is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Goss</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steven Frankel</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>James Goss</td>
<td>Barrington Research</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$100.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Steven Frankel</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$100.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Dolby Laboratories. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Dolby Laboratories compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Dolby Laboratories's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Dolby Laboratories's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/DLB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Dolby Laboratories analyst ratings.</a>
<h2>All You Need to Know About Dolby Laboratories</h2>
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
<h3>Unraveling the Financial Story of Dolby Laboratories</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Over the 3 months period, Dolby Laboratories showcased positive performance, achieving a revenue growth rate of 4.9% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Dolby Laboratories's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 19.22%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Dolby Laboratories's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 2.39%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Dolby Laboratories's ROA excels beyond industry benchmarks, reaching 1.93%. This signifies efficient management of assets and strong financial health.
Debt Management: Dolby Laboratories's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Dolby Laboratories Stock: Analyst Perspectives (4 Ratings)

Press Releases

General

Dolby Laboratories Announces Conference Call and Webcast for Q4 Fiscal 2024 Financial Results

Dolby and Jin from BTS Celebrate His New Single "I'll Be There" in Dolby Atmos

Dolby Laboratories Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Dolby Revs Up In-Car Entertainment Innovations at CES 2025

Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2025 Financial Results

Dividends

Dolby Laboratories Reports First Quarter 2025 Financial Results

Comcast and Dolby to Deliver First-Ever Super Bowl in Both Dolby Vision and Dolby Atmos

Relive the Revolution in Dolby as Purple Rain Returns Exclusively to Dolby Cinema

Dolby and General Motors Bring Dolby Atmos to Cadillac's Entire 2026 EV Lineup

Contracts

Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027

Comments

Dolby Laboratories

Interés en corto

Dolby Laboratories (NYSE:DLB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL